Author Question: A patient with a diagnosis of hepatitis C is being treated in the medical unit of the hospital and ... (Read 11 times)

jenna1

  • Hero Member
  • *****
  • Posts: 568
A patient with a diagnosis of hepatitis C is being treated in the medical unit of the hospital and has experienced a downward trend in albumin levels. In light of this diagnostic finding, what assessments should the nurse prioritize?
 
  A) Assessment of the patient's integumentary system and assessment for skin breakdown on dependent surfaces
  B) Assessment of the patient's fluid balance and assessment for third-spacing and edema
  C) Assessment of the patient's urine output, creatinine levels, and blood urea nitrogen (BUN) levels
  D) Assessment for signs and symptoms of metabolic acidosis and metabolic alkalosis

Question 2

A patient with a diagnosis of HIV exhibits a decreased level of T lymphocytes. What consequence does this state present for this patient?
 
  A) The patient will be incapable of mounting a response to allergens.
  B) The patient is particularly susceptible to infection.
  C) The patient has diminished oxygen-carrying capacity.
  D) The patient will be unable to maintain hemostasis.



AmberC1996

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

B

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library